Author:
Estey Elihu H.,Gale Robert Peter,Sekeres Mikkael A.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference22 articles.
1. Estey E, Gale RP. Acute myeloid leukemia and the chosen people. Leukemia. 2017;31:269–71.
2. White M, Holman D, Boehm J, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46:S7–15.
https://doi.org/10.1016/j.amepre.2013.10.029.
3. American Cancer Society. Barriers to patient enrollment in therapeutic clinical trials for cancer: a landscape report.
https://www.acscan.org/sites/default/files/National%20Documents/Clinical-Trials-Landscape-Report.pdf.
2018.
4. Jin S, Pazdur R, Sridhara S. Re-evaluating eligibility criteria for oncology clinical trials: analysis of investigational new drug applications in 2015. J Clin Oncol. 2017;35:3745–52.
5. Lichtman S, Harvey R, Damiette Smith MA, Rahman A, Thompson MA, Roach N, et al. Modernizing clinical trial eligibility: recommendations of the American Society of Clinical Oncology – Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group. J Clin Oncol. 2017;35:3753–9.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elihu H. Estey, MD: leukemia expert, statistician, and gentle soul (July 15, 1946–October 8, 2021);Leukemia;2021-11-16
2. Elihu H. Estey, MD: Leukaemia expert, statistician, and gentle soul (July 15, 1946–October 8, 2021);Bone Marrow Transplantation;2021-11-16
3. PIM2 and NF-κβ gene expression in a sample of AML and ALL Egyptian patients and its relevance to response to treatment;Egyptian Journal of Medical Human Genetics;2021-05-17
4. Treatment of Newly Diagnosed AML in Fit Patients;Acute Myeloid Leukemia;2021
5. Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects;Blood Advances;2020-12-08